Cagrilintide
(Long-Acting Amylin Analog)
Cagrilintide is a novel investigational peptide designed to mimic the activity of the hormone amylin, which plays a key role in appetite regulation and energy balance. It is currently being studied for its synergistic potential when combined with incretin-based agents in metabolic research. Areas of interest include:
-
Appetite Suppression
Cagrilintide is being studied for its ability to reduce food intake and enhance satiety through central appetite signaling. -
Weight Management
Researchers are exploring its role in supporting fat loss and body weight regulation by modulating gastrointestinal and neural feedback mechanisms. -
Metabolic Enhancement
The compound is under investigation for its impact on insulin sensitivity, gastric emptying, and nutrient partitioning.
How It Works
Cagrilintide is a long-acting analog of amylin, a hormone co-secreted with insulin from pancreatic beta cells. It binds to amylin receptors in the brain (particularly the area postrema and hypothalamus), influencing satiety, slowing gastric emptying, and reducing postprandial glucose spikes. When combined with GLP-1 receptor agonists, Cagrilintide may produce additive effects on appetite suppression and weight reduction—making it a promising subject in advanced metabolic and obesity-related research.
⚠️ Important Notice:
This product is sold strictly for laboratory research purposes only. It is not for human or animal use, and not for therapeutic or diagnostic applications.
By purchasing, you confirm that you are a qualified individual using this product in accordance with all applicable laws and research regulations.
